Vol. 72 No. 2 (2020)
Review Articles

ELAPE: current role in the treatment of low rectal cancer

Guillermo Bannura
Hospital Clínico San Borja-Arriaran Universidad de Chile
Bio

Published 2020-03-09

How to Cite

1.
Bannura G. ELAPE: current role in the treatment of low rectal cancer. Rev Cir. [Internet]. 2020 Mar. 9 [cited 2026 Sep. 11];72(2). Available from: https://mail.revistacirugia.cl/index.php/revistacirugia/article/view/587

Abstract

In the last decade cylindrical or extralevator abdominoperineal excision (ELAPE)  has showed a lower rate of bowel perforations and fewer positive circunferential resection margen compared with conventional excision. Unfortunately, there is conflicting evidence from meta-analyses and cooperative trials in terms of postoperative morbidity, local recurrence and long-term  survival. According to the current evidence, selective ELAPE should be the best approach en some of the cases of low rectal cancer after preoperative radiotherapy, but conventional APE is a valid option in other cases of low tumors. Clinical evaluation and magnetic resonance of the pelvis has an important role in the decision-making.